Search

Displaying results 151 - 160 of 4018 in total
  1. Drug

    Risankizumab

    go.drugbank.com/drugs/DB14762
    ApprovedInvestigational

    [L39885] It gained its first global approval in Japan in March 2019, followed by approval in Canada, the US, and Europe in April 2019.

    Products: Skyrizi Solution for Injection in Pre-filled Cartridge with On-body Injector 360mg/2.4mL
  2. Drug

    Tislelizumab

    go.drugbank.com/drugs/DB14922
    ApprovedInvestigational

    [L49439] Tislelizumab was also approved by the FDA on March 14, 2024.[L50346] It has subsequently been approved for additional cancers in the US and EU. [L49349] … [A262924] On September 25, 2023, tislelizumab gained EMA approval as a monotherapy for adults with esophageal cancer under the brand name TEVIMBRA.

  3. Drug

    Zenocutuzumab

    go.drugbank.com/drugs/DB15559
    ApprovedInvestigational

    [A264833] On December 4, 2024, the FDA granted accelerated approval to zenocutuzumab for the treatment of non-small cell lung cancer and pancreatic adenocarcinoma.

  4. Drug

    Hexaminolevulinate

    go.drugbank.com/drugs/DB06261
    ApprovedInvestigational

    On May 28, 2010, the U.S. … invasive papillary cancer of the bladder for patients suspected or known to have lesion(s) on the basis of a prior cystoscopy.

  5. Drug

    Ximelagatran

    go.drugbank.com/drugs/DB04898
    ApprovedWithdrawn

    Ximelagatran is an anticoagulant intended to become a replacement for warfarin by overcoming the dietary restrictions, drug interaction, and monitoring issues associated with the former.

  6. Drug

    Triclosan

    go.drugbank.com/drugs/DB08604
    Approved

    An aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, t...

    Mixtures: FLUOTOPIC CON FLUORProducts: Bob Barker Antibacterial Bar, Ben E. Keith Foaming Antibacterial Hand Cleaner
  7. Indication

    High risk, relapsed Neuroblastomas of the bone or bone marrow

    go.drugbank.com/conditions/DBCOND0134730
    Drugs: Naxitamab
    Synonyms: High risk, relapsed Neuroblastomas of the bone or bone marrow
  8. Indication

    Osteolysis caused by Bone Tumors

    go.drugbank.com/conditions/DBCOND0134236
    Drugs: Lidocaine
    Synonyms: Osteolysis caused by Bone Tumors
  9. Target

    Bone morphogenetic protein receptor type-1A

    go.drugbank.com/bio_entities/BE0009272
    TargetHumans

    On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SM...

    Polypeptides: Bone morphogenetic protein receptor type-1A
  10. Target

    Bone morphogenetic protein receptor type-2

    go.drugbank.com/bio_entities/BE0009324
    TargetHumans

    On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SM...

    Polypeptides: Bone morphogenetic protein receptor type-2Synonyms: Bone morphogenetic protein receptor type II